Detection of androst-4-ene-3,6,17-trione (6-OXO®) and its metabolites in urine by gas chromatography-mass spectrometry in relation to doping analysis
- 12 April 2005
- journal article
- research article
- Published by Wiley in Biomedical Chromatography
- Vol. 19 (9), 689-695
- https://doi.org/10.1002/bmc.496
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Validation of a GC‐MS screening method for anabolizing agents in solid nutritional supplementsBiomedical Chromatography, 2004
- The Prevalence of Doping in Flanders in Comparison to the Prevalence of Doping in International SportsInternational Journal of Sports Medicine, 2003
- Prohormones and sportThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Test methods: anabolicsBest Practice & Research Clinical Endocrinology & Metabolism, 2000
- Testing for natural and synthetic anabolic agents in human urineJournal of Chromatography B: Biomedical Sciences and Applications, 1996
- Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione: The 4β,5β-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active siteBiochemical Pharmacology, 1996
- Metabolism of anabolic steroids in humans: Synthesis of 6β-hydroxy metabolites of 4-chloro-1,2-dehydro-17α-methyltestosterone, fluoxymesterone, and metandienoneSteroids, 1995
- Metabolism of anabolic steroids in man: synthesis and use of reference substances for identification of anabolic steroid metabolitesAnalytica Chimica Acta, 1993
- Studies on aromatase inhibition with 4-androstene-3,6,17-trione: Its 3β-reduction and time-dependent irreversible binding to aromatase with human placental microsomesThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- ENZYME-GENERATED INTERMEDIATES DERIVED FROM 4-ANDR0STENE-3,6,17-TRI0NE AND 1,4,6-ANDR0STATRIENE-3,17-DI0NE CAUSE A TIME-DEPENDENT DECREASE IN HUMAN PLACENTAL AROMATASE ACTIVITYEndocrinology, 1981